Extrawell Pharmaceutical Holdings Limited (HKG:0858)

HKG:0858 Revenue

In the fiscal year ending March 31, 2026, Extrawell Pharmaceutical Holdings had annual revenue of 51.48M HKD, down -7.12%. Extrawell Pharmaceutical Holdings had revenue of 23.47M in the half year ending March 31, 2026. That makes Extrawell Pharmaceutical Holdings the 39,046th largest company in the world by revenue and 2,379th in Hong Kong.

• Revenue: 51.48M
• Revenue Growth: -13.84%
• P/S Ratio: 2.87
• Revenue / Employee: 325.83K
• Employees: 158
• Market Cap: 147.90M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Manufacturing 51.47M 100.0%
• Trading 12.00K 0.0%

Fiscal year ended Mar 31, 2026 See the full HKG:0858 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	51.48M	-3.95M	-7.12%
Mar 31, 2025	55.43M	-3.67M	-6.21%
Mar 31, 2024	59.10M	-13.48M	-18.57%
Mar 31, 2023	72.58M	-1.35M	-1.82%
Mar 31, 2022	73.93M	-4.88M	-6.19%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error